| Date | Title | Description |
| 11.04.2023 | Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing | PLANTATION, Fla., April 4, 2023 /PRNewswire/ -- GBI proudly announces the signing of their first Master Supply Agreement for commercializing an antibody. With the development of this new partnership, GBI's integrated CDMO biologics services... |
| 07.03.2023 | Paragonix Technologies Raises $24M in Series B Led by Signet Healthcare Partners | Leader in organ transplant technologies secures institutional growth capital to drive organ preservation innovation and commercial expansion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc., a leading organ transplant compan... |
| 06.12.2022 | Goodwin Biotechnology, Inc. Is Now GBI! | PLANTATION, FL-- Goodwin Biotechnology is becoming GBI and expanding to launch a brand-new, larger-capacity cGMP biologics facility.
Though the name may change, GBI’s mission remains the same: from clinical to commercial products, providin... |
| 24.10.2022 | LAXAI Receives Investment from SIGNET Healthcare Partners | Integrated provider of drug discovery, development, and manufacturing services to leverage SIGNET’s pharma services expertise for business growth
NEW YORK--(BUSINESS WIRE)--LAXAI Inc. (“LAXAI”) announced today that it has received a growth... |
| 20.04.2022 | Laborie Medical Technologies Acquires GI Supply | GI Supply fully integrates with Laborie as part of long-term growth strategy
PORTSMOUTH, N.H., April 20, 2022 /PRNewswire/ -- Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), anno... |
| 24.02.2022 | Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharmaceuticals Corp. | TORONTO--(BUSINESS WIRE)--Juno Pharmaceuticals Corp (“Juno”), a Canadian specialty generics pharmaceuticals company, announced that it has received a strategic growth investment from Signet Healthcare Partners (“Signet”), a New York-based h... |
| 17.01.2022 | Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform | LAVAL, Quebec--(BUSINESS WIRE)--Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept, announc... |
| 29.06.2021 | Charles River Laboratories Completes Acquisition of Vigene Biosciences | June 29, 2021 07:00 AM Eastern Daylight Time
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Vigene Biosciences, I... |
| 17.05.2021 | Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities | – Further Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy CDMO Sector –
May 17, 2021 07:00 AM Eastern Daylight Time
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc... |
| 08.04.2021 | Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners | NORTH BRUNSWICK, N.J., April 8, 2021 /PRNewswire/ -- Based in North Brunswick, NJ, Ascendia Pharmaceuticals, Inc. ("Ascendia") is a specialty contract development and manufacturing organization (CDMO) dedicated to developing and m... |
| 16.02.2021 | SMART Medical Systems receives Additional FDA Clearance for its G-EYE® Colonoscope, and Commences Clinical Work in the USA | SMART Medical has now commenced clinical collaboration with NYU Langone Health introducing its newly FDA-cleared G-EYE® 760 Colonoscope series, based on FUJIFILM Corporation's 510(k) cleared 760 colonoscopes and operating with Fujifilm's st... |
| 04.02.2021 | Vigene Biosciences Plans Major Expansion in Montgomery County | BALTIMORE, MD (February 4, 2021) — Vigene Biosciences, a global leader in gene therapy development, has announced plans to expand into a new facility in Montgomery County to accommodate industry demand for its gene and cellular therapy prod... |
| 19.01.2021 | Signet Healthcare and Bionpharma Sell CoreRx, a Leading Contract Development and Manufacturer | NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Signet Healthcare Partners and Bionpharma Inc today announced the sale of CoreRx, a global contract development and manufacturing organization ("CDMO"). Following the sale to private equ... |
| 01.09.2020 | Laborie Medical Technologies and Signet Healthcare Partners to Acquire GI Supply | Acquisition positions GI Supply for continued growth and enhances LABORIE's gastroenterology business globally
BURLINGTON, Mass., Sept. 1, 2020 /PRNewswire/ -- Laborie Medical Technologies (LABORIE), a leading diagnostic and therapeutic me... |
| 22.07.2020 | Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID™, its Single Dose Intranasal Vaccine Candidate for COVID-19 | GAITHERSBURG, Md., July 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the Company has entered into an agreement with Vigene Biosciences (“Vigene”) to manufacture... |
| 26.05.2020 | SMART Medical Systems Receives FDA Clearance for Its G-EYE® Colonoscope | SMART's G-EYE® Colonoscope, incorporating the G-EYE® Balloon Technology which helps control the endoscope's field of view and positioning during colonoscopy, was cleared for marketing in the USA by FDA
NEWS PROVIDED BY SMART Medical System... |
| 29.01.2020 | Vigene Biosciences Opens State-Of-The-Art Headquarters in Rockville, MD | “The new headquarters firmly seals Vigene’s commitment to revolutionize gene and cell therapy while rooted in Montgomery County, Maryland, USA.”
ROCKVILLE, MD. (PRWEB) JANUARY 29, 2020 -- Vigene Biosciences, a pioneer in the viral gene del... |
| 13.11.2019 | TELA Bio Announces Closing of Initial Public Offering of Common Stock | MALVERN, Pa., Nov. 13, 2019 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address... |
| 05.08.2019 | RK Pharma Inc. Secures Significant Investment in New Round of Growth Capital Financing from Signet Healthcare Partners | RK Pharma Inc. Secures Significant Investment in New Round of Growth Capital Financing from Signet Healthcare Partners
Pearl River, NY (August 5, 2019) – RK Pharma Inc. (“RK”, or “RK Pharma”, or “the Company”), a privately-owned fully vert... |
| 14.05.2019 | CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment | CLEARWATER, FL, USA, May 14, 2019 /EINPresswire.com/ -- CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment
Clearwater, Florida, May 14, 2019 — CoreRx, Inc. today announced ... |
| 29.04.2019 | Vigene Biosciences Secures Institutional Investment in New Round of Growth Capital Financing | ROCKVILLE, Md., April 29, 2019 /PRNewswire/ -- Vigene Biosciences, Inc ("Vigene") a leading provider of viral vector products and services used in gene therapy, has completed a substantial growth capital financing transaction. The... |
| 22.04.2019 | Goodwin Biotechnology Secures Significant Institutional Investment in New Round of Growth Capital Financing | FORT LAUDERDALE, Fla., April 22, 2019 /PRNewswire/ -- Goodwin Biotechnology, Inc. ("Goodwin") announced that it has completed its largest ever round of financing with growth capital which will help fund its next stage of expansion... |
| 18.04.2019 | TELA Bio® Announces 510(k) Clearance for Restella™ Reconstructive BioScaffolds for Reconstructive Surgery | Innovative product portfolio based on TELA Bio's proven technology platform advances the design of biologic-based materials for reconstructive surgery.
MALVERN, Pa., April 18, 2019 /PRNewswire/ -- TELA Bio®, Inc., a regenerative medicine c... |
| 01.04.2019 | RoundTable Healthcare Partners and Signet Healthcare Partners Establish New Platform in the Global Consumer Healthcare Market | Advantice Health Becomes a Global Consumer Healthcare Company with Category Leading Brands
LAKE FOREST, Ill., April 1, 2019 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm ... |
| 29.03.2019 | Moberg Pharma Completes the Divestment of the OTC-business for USD 155 million | STOCKHOLM, March 29, 2019 /PRNewswire/ -- Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has today completed the divestment of its OTC-business (over-the-counter) to RoundTable Healthcare Partners and Signet ... |
| 12.02.2019 | Moberg Pharma Divests Its OTC-business for USD 155 Million and Secures New Funding for MOB-015 in Transformational Transaction | STOCKHOLM, Feb. 11, 2019 /PRNewswire/ -- Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") (OMX: MOB) today announces that it has entered into agreement with a holding company owned by RoundTable Healthcare Part... |
| 15.01.2019 | Pharmaceutical Industry Veteran Dr. Kurt R. Nielsen to lead Pharmaceutics International, Inc. | HUNT VALLEY, Md., Jan. 15, 2019 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the appointment of Kurt R. ... |
| 11.06.2018 | Pii Announces Positive Inspection News from FDA and MHRA | Posted on Jun 11, 2018, 09:00 ET
HUNT VALLEY, Md., June 11, 2018 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, Maryland, received notification on Jun... |
| 28.03.2018 | pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners | Acquisition and additional funding significantly accelerate the company's
transformation to a specialty biopharmaceutical company with the potential to
commercialize two ophthalmic products in 1H 2019
Icon Bioscience's DEXYCU™ (dexamethaso... |
| 15.02.2018 | Smart Medical Systems Secures $8M in Series B Financing | RA'ANANA, Israel, February 15, 2018 /PRNewswire/ --
SMART Medical Systems Ltd., a manufacturer of innovative gastro-intestinal endoscopy products, announced today that it secured US$8 million in series B financing. The financing round was ... |
| 08.02.2018 | Pii and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017 | Posted on February 8, 2018 at 10:59 ET
HUNT VALLEY, MARYLAND (February 8, 2018) - Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, Maryland, together with their partner... |
| 05.01.2018 | Leading Pharma, LLC Receives $40 Million in Growth Capital | FAIRFIELD, N.J., Jan. 5, 2018 /PRNewswire/ -- Leading Pharma, LLC, a privately-owned generic pharmaceutical company that manufactures, markets, and distributes products to drug chains, wholesalers, and other channels, announced today that o... |
| 01.11.2017 | AltemiaTM Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD) | November 01, 2017 07:55 AM Eastern Daylight Time
RIVIERA BEACH, Fla.--(BUSINESS WIRE)--Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced positive top line results from a clinical study evaluating the efficacy and safety of Alte... |
| 25.10.2017 | Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement | Pacira to invest up to $25 million in TELA Bio to enhance commercial and clinical initiatives for distinct class of novel surgical implants for soft tissue repair
PARSIPPANY, N.J. and MALVERN, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Pacira ... |
| 03.08.2017 | Baxter Completes Acquisition of Claris Injectables | DEERFIELD, Ill., July 27, 2017 – Baxter International Inc. (NYSE: BAX), a global medical products company, today announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company.... |
| 11.01.2017 | Signet Healthcare Partners Closes $137.2 Million Life Science Fund | NEW YORK, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Signet Healthcare Partners (“Signet”), a private equity fund that provides growth capital to commercial Life Sciences companies, is pleased to announce the closing of Signet Healthcare Partners IV... |
| 09.01.2017 | leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer | leon nanodrugs GmbH appoints pharma expert Michael Mehler, Sc.D. as new CEO of the Munich based company and its U.S. subsidiary leon-nanodrugs Inc, effective today. He succeeds Dr. Theron (Ted) Odlaug who will continue to serve the company ... |
| 16.12.2016 | Baxter to Expand Portfolio of Essential Generic Injectable Medicines with Acquisition of Claris Injectables Limited | DEERFIELD, Ill., December 15, 2016 – Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today entered into a definitive agreement to acquire Claris Injectables Limited, a wholly owned subsi... |
| 19.11.2016 | Medicure Exercises Option to Acquire Majority Interest in Apicore | WINNIPEG, Nov. 18, 2016 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a leading Canadian specialty pharmaceutical company, is pleased to announce that it and a newly formed and wholly owned M... |
| 07.09.2016 | Pharmaceutics International, Inc. (Pii) Receives $93 Million in Growth Capital | HUNT VALLEY, MARYLAND (September 6, 2016) – Pharmaceutics International, Inc. (“Pii”), a contract development and manufacturing organization (“CDMO”) based in Hunt Valley, MD, announced today that it has entered into a definitive agreement ... |
| 14.03.2016 | Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy for Next-Generation Vaccines | Non-invasive integrated injection and electroporation device to enhance mass immunization against flu, RSV, and pandemic/tropical infectious diseases using transformative immune-activating technology
PLYMOUTH MEETING, Pa. - March 14, 2016 ... |
| 31.12.2015 | Bionpharma buys 25 products from specialty drug maker Banner Life Sciences | - |
| 16.10.2015 | IGI Laboratories Announces Approval For Listing On The NASDAQ Global Select Market | - |
| 16.10.2015 | IGI Laboratories, Inc. Enters Into Agreement To Acquire The Assets Of Canadian Pharmaceutical Company, Alveda Pharmaceuticals, Inc. | Acquisition Will Deliver Contribution to 2015 Financial Results
BUENA, N.J., Oct. 13, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, today announced it has entered i... |
| 08.10.2015 | Chr. Olesen Synthesis A/S Completes Financing | - |
| 07.10.2015 | IGI Laboratories, Inc. Announces Acquisition of Three Commercialized Injectable Products | - |
| 17.08.2015 | Leon-nanodrugs GmbH Raises EUR 18.5 Million In Series A Financing | TVM Capital Life Science leads international syndicate of investors - an additional EUR 3 million investment is expected later in 2015
Munich, Germany, July 27, 2015 / B3C newswire / -- leon nanodrugs GmbH today announced that it completed... |
| 09.06.2015 | Claris receives Supplemental ANDA approval for Fluconazole Injection in 50 ml PVC Bags | - |
| 09.06.2015 | Pfenex Inc. Announces Closing of Public Offering of Common Stock | - |
